Roche’s Good-Cholesterol Booster Looks Promising

Swiss drug giant Roche said today that its experimental drug for raising good cholesterol didn’t trip any safety alarms in a mid-stage clinical test. That passes for good news because the drug, code-named R1658, is in the same class as Pfizer’s doomed blockbuster wanna-be torcetrapib, which failed a couple years ago because more people on [...]